pegzilarginase-nbln

pegzilarginase-nbln (LOARGYS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

LOARGYS is a marketed brand name for pegzilarginase-nbln. Check FDA Drugs@FDA for the current US label holder and prescribing information.

pegzilarginase-nbln has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.